InvestLog
CRVS Corvus Pharmaceuticals, Inc. logo

CRVS Corvus Pharmaceuticals, Inc.

Healthcare
$12.88+0.00%OpenMarket Cap: $1.08B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

3

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+36,932

Shares Acquired

36,932

Shares Disposed

0

Total Bought ($)

$2.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed May 20MILLER RICHARD A MDdirector, officer: President and CEOBuy5,000$12.051,193,103
Wed May 20MILLER RICHARD A MDdirector, officer: President and CEOBuy1,932$12.011,195,035
Mon Apr 27Chan Andrew C.directorSell30,000$16.0230,000
Mon Apr 27Chan Andrew C.Sell0$0.000
Fri Jan 30Thompson Peter A.director, 10 percent owner: Sell15,000$2.12210,000